PCBD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 2.97459834541769E-11
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
3.334300E-02
Normal-vs-Stage2
1.48830003876554E-09
Normal-vs-Stage3
3.875800E-02
Normal-vs-Stage4
6.343400E-01
Stage1-vs-Stage2
8.277500E-02
Stage1-vs-Stage3
8.876600E-03
Stage1-vs-Stage4
2.391600E-01
Stage2-vs-Stage3
1.740380E-02
Stage2-vs-Stage4
6.854600E-01
Stage3-vs-Stage4
1.774380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
8.54459836219235E-11
Normal-vs-AfricanAmerican
7.539200E-01
Normal-vs-Asian
1.543980E-01
Caucasian-vs-AfricanAmerican
2.269000E-01
Caucasian-vs-Asian
7.853800E-01
AfricanAmerican-vs-Asian
2.300400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
7.17870000110921E-08
Normal-vs-Female
8.00550000000788E-05
Male-vs-Female
2.248400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
7.271500E-02
Normal-vs-Age(41-60Yrs)
4.89479999976616E-07
Normal-vs-Age(61-80Yrs)
2.31379999999781E-05
Normal-vs-Age(81-100Yrs)
1.342790E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.687800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.131200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.970000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.550410E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.845800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.335600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
4.265000E-03
Normal-vs-Daily Drinker
4.660300E-03
Normal-vs-Weekly Drinker
4.697800E-01
Normal-vs-Occasional Drinker
8.357500E-03
Normal-vs-Social Drinker
1.763720E-02
Non Drinker-vs-Daily Drinker
7.226400E-01
Non Drinker-vs-Weekly Drinker
3.188000E-01
Non Drinker-vs-Occasional Drinker
4.572800E-01
Non Drinker-vs-Social Drinker
8.530200E-01
Daily Drinker-vs-Weekly Drinker
2.294000E-01
Daily Drinker-vs-Occasional Drinker
2.884800E-01
Daily Drinker-vs-Social Drinker
8.942600E-01
Weekly Drinker-vs-Occasional Drinker
6.148400E-01
Weekly Drinker-vs-Social Drinker
3.067000E-01
Occasional Drinker-vs-Social Drinker
3.860000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
3.333700E-02
Normal-vs-Grade 2
3.418300E-03
Normal-vs-Grade 3
3.956000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.262600E-01
Grade 1-vs-Grade 3
4.460200E-01
Grade 1-vs-Grade 4
3.333700E-02
Grade 2-vs-Grade 3
6.119400E-01
Grade 2-vs-Grade 4
3.418300E-03
Grade 3-vs-Grade 4
3.956000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
4.674200E-02
Normal-vs-NonDiabetic
6.0825000591791E-10
Diabetic-vs-NonDiabetic
5.357900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
1.466110E-02
Normal-vs-NoPancreatitis
2.06200000407719E-08
Pancreatitis-vs-NoPancreatitis
5.329600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
4.09129999999758E-05
Normal-vs-N1
2.17169999983113E-07
N0-vs-N1
2.886000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
9.354400E-02
Normal-vs-TP53-NonMutant
2.848400E-01
TP53-Mutant-vs-TP53-NonMutant
1.049010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap